Nevin Abernethy - Anteo Diagnostics Insider

ADO -- Australia Stock  

AUD 0.019  0.001  5.56%

Chief Product Development and Research Officer
Dr. Nevin Abernethy Ph.D. is Chief Product Development and Research Officer of Anteo Diagnostics Limited. He was awarded his PhD in animal physiology by the University of Toronto Canada in 1989. After working as a Research Officer and lecturer at the University of Melbournes Department of Veterinary and PreClinical Sciences he moved to Auckland New Zealand where he was a Research Fellow in the Department of Molecular Medicine at the University of Auckland prior to joining Genesis Research and Development Corporationration at the time the biotech company in New Zealand. Nevin is named as an inventor on a number of patents in the area of therapeutics and immunological diseases has published numerous peer reviewed papers in related areas and has demonstrated in product development programs similar to those of interest to BioLayer.
  Executive Since 2007      
61 7 3219 0085  http://www.anteodx.com

Management Efficiency

The company has return on total asset (ROA) of (9.06) % which means that it has lost $9.06 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (61.43) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Christine ParkerWestpac Banking Corporation
2011
Adam BennettCommonwealth Bank of Australia
2015
Caryn KatsikogianisWoolworths Group Limited
2016
Rachel AgnewBHP Billiton Limited
2014
Adrian WentAustralia and New Zealand Banki
2018
Kathryn MerweAustralia and New Zealand Banki
2017
Kate GriffithsBHP Billiton Limited
2014
Philip RichardsRio Tinto Limited
2017
Jill CraigAustralia and New Zealand Banki
N/A
Maya DriesenWesfarmers Limited
2015
Annabel SpringCommonwealth Bank of Australia
2011
Tara DinesBHP Billiton Limited
N/A
David CohenCommonwealth Bank of Australia
2016
David LindbergWestpac Banking Corporation
2015
Michele HueyTransurban Group
2014
Gary ThursbyWestpac Banking Corporation
2016
Alexis GeorgeAustralia and New Zealand Banki
2018
Anna LenahanCommonwealth Bank of Australia
2016
Vera KirikovaRio Tinto Limited
2017
Joanne FarrellRio Tinto Limited
2016
Kevin CorballyAustralia and New Zealand Banki
2018

Entity Summary

Anteo Diagnostics Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences, clinical diagnostics, and bioseparations markets. Anteo Diagnostics Limited is based in Eight Mile Plains, Australia. Anteo Diagnostics is traded on Australian Securities Exchange in Australia.Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in 4/26 Brandl Street and employs 99 people.

Anteo Diagnostics Limited Leadership Team

Nobuyoshi Maeji, Executive, Ph.D
Alan Studley, Director, CPA
John Hamilton, Chairman, Ph.D
Mark Bouris, Chairman
Peter HardingSmith, CFO
Matthew Sanderson, Director
John Hurrell, Director, Ph.D
Stefan Enderling, CEO, Ph.D
Geoffrey Cumming, CEO
Tamara Mills, COO
Julien McInally, Executive, CPA
Shane Hartwig, Executive
Nevin Abernethy, Executive
Richard Martin, Director
Jef Vangenechten, CEO, Ph.D
Rolf Sickman, Director
Sandra Andersen, Director, CPA

Stock Performance Indicators

Did you try this?

Run Pair Correlation Now
   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
All  Next Launch Pair Correlation

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Anteo Diagnostics and BHP Billiton Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.